This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
这位标普全球分析师在看好的基调下开始了覆盖；以下是周五的五大启动推荐
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
顶级华尔街分析师改变了他们对这些顶级股票的看法。有关所有分析师评级变动的完整信息，包括评级上调和下调，请查看我们的分析师评级页面。
- Wells Fargo analyst Tiago Fauth initiated coverage on MannKind Corporation (NASDAQ:MNKD) with an Overweight rating and announced a price target of $9. MannKind shares closed at $6.30 on Thursday. See how other analysts view this stock.
- Citigroup analyst Peter Christiansen initiated coverage on S&P Global Inc. (NYSE:SPGI) with a Buy rating and announced a price target of $600. S&P Global shares closed at $486.56 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Alexander Hess initiated coverage on Fair Isaac Corporation (NYSE:FICO) with a Neutral rating and announced a price target of $2150. Fair Isaac shares closed at $2,044.89 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Andrew Fein initiated coverage on Avidity Biosciences, Inc. (NASDAQ:RNA) with a Buy rating and announced a price target of $72. Avidity Biosciences shares closed at $31.05 on Thursday. See how other analysts view this stock.
- Chardan Capital analyst Rudy Li initiated coverage on Prothena Corporation plc (NASDAQ:PRTA) with a Buy rating and announced a price target of $40. Prothena shares closed at $16.01 on Thursday. See how other analysts view this stock.
- 富国银行分析师Tiago Fauth对曼恩凯德生物医疗公司（纳斯达克：MNKD）进行了覆盖，给予了“增持”评级，并宣布目标价为9美元。曼恩凯德的股票在周四收于6.30美元。看看其他分析师如何看待这只股票。
- 花旗集团分析师彼得·克里斯滕森对S&P全球公司（纽交所：SPGI）启动了覆盖，给予买入评级，并 announced 目标价格为600美元。S&P全球的股价周四收于486.56美元。看看其他分析师如何看待这只股票。
- 摩根大通分析师Alexander Hess对Fair Isaac公司（纽交所：FICO）进行了覆盖，给予了“中立”评级，并宣布目标价为2150美元。Fair Isaac的股票在周四收于2,044.89美元。看看其他分析师如何看待这只股票。
- HC Wainwright & Co.分析师Andrew Fein对Avidity Biosciences, Inc.（纳斯达克：RNA）进行了覆盖，给予了“买入”评级，并宣布目标价为72美元。Avidity Biosciences的股票在周四收于31.05美元。看看其他分析师如何看待这只股票。
- Chardan Capital分析师Rudy Li对Prothena Corporation plc（纳斯达克：PRTA）进行了覆盖，给予了“买入”评级，并宣布目标价为40美元。Prothena的股票在周四收于16.01美元。看看其他分析师如何看待这只股票。
Considering buying SPGI stock? Here's what analysts think:
考虑购买SPGI股票吗？以下是分析师的看法：
Read This Next:
接下来请阅读：
- Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock
- 吉姆·克莱默喜欢沃尔玛，推荐购买这只“非常非常好”的金融股票
资讯热榜
更新时间